Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qinghong Han

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
In Vivo (Athens, Greece)|August 19, 2021
Efficacy of Oral Recombinant Methioninase and Eribulin on a PDOX Model of Triple-negative Breast Cancer (TNBC) Liver MetastasisHye In Lim, Y U Sun, Qinghong Han, et al.
Cancer Diagnosis & Prognosis|May 6, 2024
Efficacy of Recombinant Methioninase on Late-stage Patient Cancer in the Histoculture Drug Response Assay (HDRA) as a Potential Functional Biomarker of Sensitivity to Methionine-restriction Therapy in the ClinicYutaro Kubota, Masato Sasaki, Qinghong Han, et al.
Anticancer Research|December 30, 2022
Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal CarcinomatosisMin Jeong Kim, Qinghong Han, Michael Bouvet, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2019
Pilot Phase I Clinical Trial of Methioninase on High-Stage Cancer Patients: Rapid Depletion of Circulating MethionineRobert M Hoffman, Yuying Tan, Shukuan Li, et al.
Anticancer Research|December 31, 2024
Comparison of Cell-death Kinetics of Recombinant Methioninase (rMETase)-treated Cancer and Normal Cells: Only Cancer Cells Undergo Methionine-depletion Catastrophe at Low rMETase ConcentrationsByung Mo Kang, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research|November 28, 2008
Human tumor growth in nude mice is associated with decreased plasma cysteine and homocysteineFarida Al-Awadi, Meng Yang, Yuying Tan, et al.
Biochemistry. Biokhimiia|September 26, 2023
Targeting Methionine Addiction of Cancer Cells with MethioninaseVadim S Pokrovsky, Louay Abo Qoura, Elena A Demidova, et al.
Clinical Chemistry|August 27, 2002
Homogeneous, nonradioactive, enzymatic assay for plasma pyridoxal 5-phosphateQinghong Han, Mingxu Xu, Li Tang, et al.
Anticancer Research|March 28, 2025
Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their Combination on <i>BRCA1</i> Mutant and Wild-type Triple-negative Breast Cancer Cell LinesMayuko Miki, Sachiko Inubushi, Qinghong Han, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2019
High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of CancerRobert M Hoffman, Takashi Murakami, Kei Kawaguchi, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
In Vivo (Athens, Greece)|August 19, 2021
Efficacy of Oral Recombinant Methioninase and Eribulin on a PDOX Model of Triple-negative Breast Cancer (TNBC) Liver MetastasisHye In Lim, Y U Sun, Qinghong Han, et al.
Cancer Diagnosis & Prognosis|May 6, 2024
Efficacy of Recombinant Methioninase on Late-stage Patient Cancer in the Histoculture Drug Response Assay (HDRA) as a Potential Functional Biomarker of Sensitivity to Methionine-restriction Therapy in the ClinicYutaro Kubota, Masato Sasaki, Qinghong Han, et al.
Anticancer Research|December 30, 2022
Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal CarcinomatosisMin Jeong Kim, Qinghong Han, Michael Bouvet, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2019
Pilot Phase I Clinical Trial of Methioninase on High-Stage Cancer Patients: Rapid Depletion of Circulating MethionineRobert M Hoffman, Yuying Tan, Shukuan Li, et al.
Anticancer Research|December 31, 2024
Comparison of Cell-death Kinetics of Recombinant Methioninase (rMETase)-treated Cancer and Normal Cells: Only Cancer Cells Undergo Methionine-depletion Catastrophe at Low rMETase ConcentrationsByung Mo Kang, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research|November 28, 2008
Human tumor growth in nude mice is associated with decreased plasma cysteine and homocysteineFarida Al-Awadi, Meng Yang, Yuying Tan, et al.
Biochemistry. Biokhimiia|September 26, 2023
Targeting Methionine Addiction of Cancer Cells with MethioninaseVadim S Pokrovsky, Louay Abo Qoura, Elena A Demidova, et al.
Clinical Chemistry|August 27, 2002
Homogeneous, nonradioactive, enzymatic assay for plasma pyridoxal 5-phosphateQinghong Han, Mingxu Xu, Li Tang, et al.
Anticancer Research|March 28, 2025
Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their Combination on <i>BRCA1</i> Mutant and Wild-type Triple-negative Breast Cancer Cell LinesMayuko Miki, Sachiko Inubushi, Qinghong Han, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2019
High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of CancerRobert M Hoffman, Takashi Murakami, Kei Kawaguchi, et al.
Pageof 15